ReverePhilipKinkelMDFAAN

Neuroimmunology/Multiple Sclerosis

Director of Multiple Sclerosis Program, University of California San Diego

Dr. Kinkel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Cleveland Clinic FoundationResidency, Neurology, 1987 - 1990
SUNY at Buffalo Graduate Medical-Dental Education Consortium (Millard Fillmore)Internship, Internal Medicine, 1986 - 1987
Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1986

PubMed

30 citations
Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation
Mark P. Gorman, Meredith R. Golomb, Laurence E. Walsh, Grace M. Hobson, James Y. Garbern
Neurology. 2007-04-17
78 citations
Focal cortical lesion detection in multiple sclerosis: 3 Tesla DIR versus 7 Tesla FLASH-T2.
A. Scott Nielsen, R. Philip Kinkel, Emanuele Tinelli, Thomas Benner, Julien Cohen-Adad
Journal of Magnetic Resonance Imaging. 2012-03-01
53 citations
Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI.
Constantina A. Treaba, Tobias Granberg, Maria Pia Sormani, Elena Herranz, Russell Ouellette
Radiology. 2019-04-09

Study Finds Why Some Drugs May Trigger Lethal Brain DiseaseDecember 17th, 2022
Study Offers a Genetic Explanation for Why Some Drugs Trigger a Deadly Brain DiseaseDecember 14th, 2022
Doing No Harm in the World of Disease-Modifying TreatmentsApril 16th, 2019